Aripiprazole Lauroxil Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as ALKERMES INC. It is marketed under 2 brand names, including ARISTADA, ARISTADA INITIO KIT. Available in 5 different strengths, such as 441MG/1.6ML (275.63MG/ML), 662MG/2.4ML (275.83MG/ML), 882MG/3.2ML (275.63MG/ML) and others, and administered through 1 route including SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"82043","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"2e73e2f44ffa464abaa9","publication_number":"US10112903B2","cleaned_patent_number":"10112903","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-24","publication_date":"2018-10-30","legal_status":"Granted"} US10112903B2 Molecular 30 Oct, 2018 Granted 24 Jun, 2030
{"application_id":"82003","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"2e73e2f44ffa464abaa9","publication_number":"US8796276B2","cleaned_patent_number":"8796276","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-24","publication_date":"2014-08-05","legal_status":"Granted"} US8796276B2 05 Aug, 2014 Granted 24 Jun, 2030
{"application_id":"82038","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"2e73e2f44ffa464abaa9","publication_number":"US8431576B2","cleaned_patent_number":"8431576","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-26","publication_date":"2013-04-30","legal_status":"Granted"} US8431576B2 Molecular 30 Apr, 2013 Granted 26 Oct, 2030
{"application_id":"81997","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"da03e299e24b4b3385f8","publication_number":"US10226458B2","cleaned_patent_number":"10226458","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-19","publication_date":"2019-03-12","legal_status":"Granted"} US10226458B2 12 Mar, 2019 Granted 19 Mar, 2032
{"application_id":"81961","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"da03e299e24b4b3385f8","publication_number":"US9034867B2","cleaned_patent_number":"9034867","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-11-07","publication_date":"2015-05-19","legal_status":"Granted"} US9034867B2 Formulation 19 May, 2015 Granted 07 Nov, 2032
{"application_id":"81956","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"cbebe35cb212412fb9b8","publication_number":"US11097006B2","cleaned_patent_number":"11097006","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-10-24","publication_date":"2021-08-24","legal_status":"Granted"} US11097006B2 Formulation 24 Aug, 2021 Granted 24 Oct, 2033
{"application_id":"81941","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"cbebe35cb212412fb9b8","publication_number":"US9193685B2","cleaned_patent_number":"9193685","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-10-24","publication_date":"2015-11-24","legal_status":"Granted"} US9193685B2 Formulation 24 Nov, 2015 Granted 24 Oct, 2033
{"application_id":"81936","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"6cd029f526d2459aace3","publication_number":"US10238651B2","cleaned_patent_number":"10238651","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-03-19","publication_date":"2019-03-26","legal_status":"Granted"} US10238651B2 26 Mar, 2019 Granted 19 Mar, 2035
{"application_id":"81938","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"6cd029f526d2459aace3","publication_number":"US11406632B2","cleaned_patent_number":"11406632","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-03-19","publication_date":"2022-08-09","legal_status":"Granted"} US11406632B2 09 Aug, 2022 Granted 19 Mar, 2035
{"application_id":"81917","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"6cd029f526d2459aace3","publication_number":"US9452131B2","cleaned_patent_number":"9452131","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-03-19","publication_date":"2016-09-27","legal_status":"Granted"} US9452131B2 27 Sep, 2016 Granted 19 Mar, 2035
{"application_id":"81937","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"6cd029f526d2459aace3","publication_number":"US10813928B2","cleaned_patent_number":"10813928","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-03-19","publication_date":"2020-10-27","legal_status":"Granted"} US10813928B2 27 Oct, 2020 Granted 19 Mar, 2035
{"application_id":"81934","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"6cd029f526d2459aace3","publication_number":"US9526726B2","cleaned_patent_number":"9526726","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-03-19","publication_date":"2016-12-27","legal_status":"Granted"} US9526726B2 Formulation 27 Dec, 2016 Granted 19 Mar, 2035
{"application_id":"82106","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA INITIO KIT","family_id":"d1d07d2103ab49108658","publication_number":"US11154552B2","cleaned_patent_number":"11154552","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-08-17","publication_date":"2021-10-26","legal_status":"Granted"} US11154552B2 Formulation 26 Oct, 2021 Granted 17 Aug, 2035
{"application_id":"82105","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA INITIO KIT","family_id":"d1d07d2103ab49108658","publication_number":"US10688091B2","cleaned_patent_number":"10688091","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-08-17","publication_date":"2020-06-23","legal_status":"Granted"} US10688091B2 Formulation 23 Jun, 2020 Granted 17 Aug, 2035
{"application_id":"82067","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA INITIO KIT","family_id":"d1d07d2103ab49108658","publication_number":"US10849894B2","cleaned_patent_number":"10849894","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-08-17","publication_date":"2020-12-01","legal_status":"Granted"} US10849894B2 01 Dec, 2020 Granted 17 Aug, 2035
{"application_id":"82104","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA INITIO KIT","family_id":"d1d07d2103ab49108658","publication_number":"US10016415B2","cleaned_patent_number":"10016415","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-09-08","publication_date":"2018-07-10","legal_status":"Granted"} US10016415B2 Formulation 10 Jul, 2018 Granted 08 Sep, 2035
{"application_id":"82058","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"df1c48fadcde4cb8af24","publication_number":"US11273158B2","cleaned_patent_number":"11273158","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-04-06","publication_date":"2022-03-15","legal_status":"Granted"} US11273158B2 15 Mar, 2022 Granted 06 Apr, 2039
{"application_id":"82064","ingredient":"ARIPIPRAZOLE LAUROXIL","trade_name":"ARISTADA","family_id":"df1c48fadcde4cb8af24","publication_number":"US20220152021A1","cleaned_patent_number":"12251381","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-04-09","publication_date":"2022-05-19","legal_status":"Pending"} US12251381B2 19 May, 2022 Pending 09 Apr, 2039

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Aripiprazole Lauroxil

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.